ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BridgeBio Stock Up 60% So Far In Dec., IPO Lockup Period Expires Today
December 25, 2019Shares of BridgeBio Pharma have gone up 60% so far in December, as the clinical-stage biopharmaceutical company focused on developing medicines for genetic diseases gears up for some important events in the months ahead, reported Markets Insider. -
BridgeBio Pharma raises $299m to support drug R&D
January 25, 2019US-based biopharmaceutical firm BridgeBio Pharma has raised $299.2m in a new financing round led by its existing investors KKR and Viking Global Investors..... -
BridgeBio Pharma gets $135M for genetic disease work
September 18, 2017The company will use the cash to boost the work on its early-stage discovery and development programs, with the goal of creating genetically targeted therapeutics
Pharma Sources Insight January 2025
